نتائج البحث - "romosozumab"

1

Antisclerostin effect on osseointegration and bone remodeling : a systematic review

المؤلفون: Couto, Bárbara Alexandra do Amaral

المساهمون: Fernandes, Gustavo Vicentis de Oliveira, Castilho, Rogério Moraes de, Veritati - Repositório Institucional da Universidade Católica Portuguesa

مصطلحات موضوعية: Antisclerostin, Sclerostin antibody, Romosozumab, Osseointegration, Bone remodeling, Bone formation, Antiesclerostina, Anticorpo esclerostina, Osseointegração, Remodelação óssea, Formação óssea, Domínio/Área Científica::Ciências Médicas::Outras Ciências Médicas

وصف الملف: application/pdf

الإتاحة: http://hdl.handle.net/10400.14/36494Test

View record in RCAAP

2

دورية أكاديمية

Assessment of romosozumab efficacy in the treatment of postmenopausal osteoporosis: Results from a mechanistic PK-PD mechanostat model of bone remodeling

المؤلفون: Martin, Madge, Sansalone, Vittorio, Cooper, David M.L., Forwood, Mark R., Pivonka, Peter

المصدر: Bone

مصطلحات موضوعية: Bone remodeling, Frost's mechanostat, Patient-specific therapy, Pharmacodynamics, Pharmacokinetics, Postmenopausal osteoporosis, Romosozumab

وصف الملف: application/pdf

العلاقة: https://eprints.qut.edu.au/198137/1/56673046.pdfTest; Martin, Madge, Sansalone, Vittorio, Cooper, David M.L., Forwood, Mark R., & Pivonka, Peter (2020) Assessment of romosozumab efficacy in the treatment of postmenopausal osteoporosis: Results from a mechanistic PK-PD mechanostat model of bone remodeling. Bone, 133, Article number: 115223.; https://eprints.qut.edu.au/198137Test/; Centre for Biomedical Technologies; Institute of Health and Biomedical Innovation; Faculty of Engineering

الإتاحة: https://doi.org/10.1016/j.bone.2020.115223Test
https://eprints.qut.edu.au/198137Test/

View record in BASE

3

Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review

المؤلفون: Willem F. Lems, Hennie G. Raterman, Laura P. B. Elbers

المصدر: Drugs
Elbers, L P B, Raterman, H G & Lems, W F 2021, ' Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review ', Drugs, vol. 81, no. 14, pp. 1645-1655 . https://doi.org/10.1007/s40265-021-01587-xTest

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a84808e5828eb1c382c5249746ced5Test
https://doi.org/10.1007/s40265-021-01587-xTest

4

Glucocorticoid-Induced Osteoporosis: The Potential Role of Romosozumab

المؤلفون: Jacqueline So, Chi Chiu Mok

المصدر: Journal of Clinical Rheumatology and Immunology, Vol 20, Iss 2, Pp 71-79 (2020)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2424305e1ac73c475c553ddbd6aa672bTest
https://doi.org/10.1142/s2661341720300074Test

5

كتاب

Antibody Treatment and Osteoporosis: Clinical Perspective

المؤلفون: Brunetti G., Todisco S., Grano M.

المساهمون: Andy H. Choi, Besim Ben-Nissan, Brunetti, G., Todisco, S., Grano, M.

مصطلحات موضوعية: Bone remodeling, Denosumab, Osteoporosi, RANKL, Romosozumab, Sclerostin

العلاقة: info:eu-repo/semantics/altIdentifier/isbn/978-981-16-7438-9; info:eu-repo/semantics/altIdentifier/isbn/978-981-16-7439-6; ispartofbook:Springer Series in Biomaterials Science and Engineering; volume:18; firstpage:111; lastpage:126; numberofpages:16; serie:SPRINGER SERIES IN BIOMATERIALS SCIENCE AND ENGINEERING; http://hdl.handle.net/11586/381999Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85122372005

الإتاحة: https://doi.org/10.1007/978-981-16-7439-6_6Test
http://hdl.handle.net/11586/381999Test

View record in BASE